Refining Allogeneic Blood and Marrow Transplantation As a Safe and Curative Option for Patients with Transfusion-Dependent Thalassemia – a Single Center Experience

Key Points

• Allogeneic blood and marrow transplantation provides a safe and effective curative option for thalassemia patients.
• The procedure significantly reduces the need for regular blood transfusions in affected individuals.
• Analysis indicates positive outcomes post-transplant with a focus on patient safety.
• These findings suggest that allogeneic transplantation may serve as a primary treatment for severe thalassemia.